MSD R&D China

MSD R&D China is the research and development arm of the global pharmaceutical company MSD, known as Merck & Co., Inc. in the United States and Canada. Based in Beijing, the center serves as one of MSD's primary global R&D hubs, focusing on clinical development and translational research tailored to the Asia-Pacific region. The facility plays a critical role in MSD's global innovation strategy, managing extensive clinical trial portfolios in oncology, infectious diseases, and vaccines. By integrating local clinical data and regulatory expertise, MSD R&D China accelerates the delivery of breakthrough therapies to patients in China. The organization collaborates extensively with local healthcare providers and academic institutions to address significant public health challenges, including cancer and viral hepatitis.